Free Access
J Extra Corpor Technol
Volume 37, Number 1, March 2005
Page(s) 9 - 14
Published online 15 March 2005
  1. Chavez AM, Cosgrove DM. Blood conservation. Semin Thorac Cardiovasc Surg. 1990;2:358–63. [Google Scholar]
  2. Breyer RH, Engelman RM, Rousou JA, Lemeshow SA. A comparison of cell saver versus ultrafilter during coronary artery bypass operations. J Thorac Cardiovasc Surg. 1985;90:736–40. [CrossRef] [Google Scholar]
  3. Hall RI, Schweiger IM, Finlayson DC. The benefit of the Hemonetics cell saver apparatus during cardiac surgery. Can J Anaesth. 1990;37:618–23. [CrossRef] [PubMed] [Google Scholar]
  4. Boldt J, Kling D, Zickmann B, Jacobi M, Dapper F, Hempelmann G. Acute preoperative plasmapheresis and established blood conservation techniques. Ann Thorac Surg. 1990;50:62–8. [CrossRef] [Google Scholar]
  5. Gravlee GP. Autologous platelet-rich plasma in cardiac surgery: aesthetics versus virtue. J Cardiothorac Vasc Anesth. 1993;7:1–3. [CrossRef] [Google Scholar]
  6. Boldt J, Zickmann B, Ballesteros M, Oehmke S, Stertmann F, Hempelmann G. Influence of acute preoperative plasmapheresis on platelet function in cardiac surgery. J Cardiothorac Vasc Anesth. 1993;7:4–9. [CrossRef] [Google Scholar]
  7. Smith PK, Datta SK, Muhlbaier LH, Samsa G, Nadel A, Lipscomb J. Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials. Ann Thorac Surg. 2004;77:635–42. [CrossRef] [Google Scholar]
  8. Hu XQ, Liu MZ, Wu LM, et al. Application of different dose aprotinin on open-heart surgery. Chin Circ J. 1995;10:110–2. [Google Scholar]
  9. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood. 1990;76:1680–97. [CrossRef] [PubMed] [Google Scholar]
  10. Spanier TB, Chen JM, Oz MC, et al. Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1998;116:860–9. [CrossRef] [Google Scholar]
  11. Gil W. Inflammo-coagulatory response, extrinsic pathway thrombin generation and a new theory of activated clotting time interpretation. Perfusion. 2001;16:27–35. [CrossRef] [PubMed] [Google Scholar]
  12. Gu YJ, Huyzen RJ, van Oeveren W. Extrinsic pathway–associated activated clotting time for anticoagulation monitoring during cardiopulmonary bypass. Anesth Analg. 1996;83:433. [CrossRef] [PubMed] [Google Scholar]
  13. Sonntag J, Dahnert I, Stiller B, Hetzer R, Lange PE. Complement and contact activation during cardiovascular operations in infants. Ann Thorac Surg. 1998;65:525–31. [CrossRef] [Google Scholar]
  14. Bertolino G, Locatelli A, Noris P, et al. Platelet composition and function in patients undergoing cardiopulmonary bypass for heart surgery. Haematologica. 1996;81:116–20. [PubMed] [Google Scholar]
  15. Levy JH, Cormack JG, Morales A. Heparin neutralization by recombinant platelet factor 4 and protamine. Anesth Analg. 1995;81:35–7. [Google Scholar]
  16. Schlame M, Schmid AB, Haupt R, Rustow B, Kox WJ. Study of platelet-activating factor acetylhydrolase in the perioperative period of patients undergoing cardiac surgery. Shock. 1998;9:313–9. [CrossRef] [PubMed] [Google Scholar]
  17. Rinder C, Fitch J. Amplification of the inflammatory response: adhesion molecules associated with platelet/white cell responses. J Cardiovasc Pharmacol. 1996;27:S6–12. [CrossRef] [Google Scholar]
  18. Kawahito K, Kobayashi E, Ohmori M, et al. Enhanced responsiveness of circulatory neutrophils after cardiopulmonary bypass: increased aggregability and superoxide producing capacity. Artif Organs. 2000;24:37–42. [CrossRef] [PubMed] [Google Scholar]
  19. Ilton MK, Langton PE, Taylor ML, et al. Differential expression of neutrophil adhesion molecules during coronary artery surgery with cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1999;118:930–37. [CrossRef] [Google Scholar]
  20. Baufreton C, Intrator L, Jansen PG, et al. Inflammatory response to cardiopulmonary bypass using roller or centrifugal pumps. Ann Thorac Surg. 1999;67:972–7. [CrossRef] [Google Scholar]
  21. Pintar T, Collard CD. The systemic inflammatory response to cardiopulmonary bypass. Anesthesiol Clin North America. 2003;21:453–64. [CrossRef] [Google Scholar]
  22. Holloway DS, Summaria L, Sandesara J, Vagher Jp, Alexander JC, Caprini JA. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost. 1988;59:62–7. [Google Scholar]
  23. Wenger RK, Lukasiewicz H, Mikuta BS, Niewiarowski S, Edmunds LH. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1989;97:235–9. [CrossRef] [Google Scholar]
  24. Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Simth BR. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology. 1991;75:563–70. [CrossRef] [PubMed] [Google Scholar]
  25. Mohr R, Goor DA, Lusky A, Lavee J. Aprotinin prevents cardiopulmonary bypass–induced platelet dysfuanction. Circulation. 1992;86(Suppl 2):405–9. [Google Scholar]
  26. Blauhut B, Gross C, Necek S, Doran JE, Spath P, Hansen PL. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991;101:958–67. [CrossRef] [Google Scholar]
  27. Lass M, Welz A, Kochs M, Mayer G, Schwandt M, Hannekum A. Aprotinin in elective primary bypass surgery. Graft patency and clinical efficacy. Eur J Cardiothorac Surg. 1995;9:206–10. [CrossRef] [Google Scholar]
  28. Royston D. Blood-sparing drugs: aprotinin, tranexamic acid, and epsilon-aminocaproic acid. Int Anesthesiol Clin. 1995;33:155–79. [CrossRef] [PubMed] [Google Scholar]
  29. Shinfeld A, Zippel D, Lavee J, et al. Aprotinin improves hemostasis after cardiopulmonary bypass better than single-donor platelet concentrate. Ann Thorac Surg. 1995;59:872–6. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.